ENKEPHALINS AND NIGROSTRIATAL FUNCTIONDIAMOND BI; BORISON RL.1978; NEUROLOGY; USA; DA. 1978; VOL. 28; NO 11; PP. 1085-1088; BIBL. 11 REF.Article

A NEW ANIMAL MODEL FOR SCHIZOPHRENIA: INTERACTIONS WITH ADRENERGIC MECHANISMS.BORISON RL; DIAMOND BI.1978; BIOL. PSYCHIATRY; USA; DA. 1978; VOL. 13; NO 2; PP. 217-225; BIBL. 1 P. 1/2Article

A NEW PUTATIVE NEUROREGULATOR OF THE EXTRAPYRAMIDAL SYSTEMDIAMOND BI; BORISON RL.1978; PHARMACOLOGY; CHE; DA. 1978; VOL. 17; NO 4; PP. 210-214; BIBL. 22 REF.Article

BIOSYNTHESIS OF BRAIN 2-PHENYLETHYLAMINE: INFLUENCE OF DECARBOXYLASE INHIBITORS AND D-AMPHETAMINE = BIOSYNTHESE DE LA PHENYL-2 ETHYLAMINE CEREBRALE: INFLUENCE DES INHIBITEURS DE LA DECARBOXYLASE ET DE LA D-AMPHETAMINEBORISON RL; MOSNAIM AD; SABELLI HC et al.1974; LIFE SCI.; G.B.; DA. 1974; VOL. 15; NO 10; PP. 1837-1848; BIBL. 2P.Article

CHRONIC PHENYLETHYLAMINE STEREOTYPY IN RATS: A NEW ANIMAL MODEL FOR SCHIZOPHRENIA.BORISON RL; HAVDALA HS; DIAMOND BI et al.1977; LIFE SCI.; G.B.; DA. 1977; VOL. 21; NO 1; PP. 117-122; BIBL. 28 REF.Article

BRAIN 2-PHENYLETHYLAMINE AS A MAJOR MEDIATOR FOR THE CENTRAL ACTIONS OF AMPHETAMINE AND METHYLPHENIDATE. = LA PHENYL-2 ETHYLAMINE DU CERVEAU COMME PRINCIPAL MEDIATEUR DES ACTIONS CENTRALES DE L'AMPHETAMINE ET DU METHYLPHENIDATEBORISON RL; MOSNAIM AD; SABELLI HC et al.1975; LIFE SCI.; G.B.; DA. 1975; VOL. 17; NO 8; PP. 1331-1343; BIBL. 1 P.Article

ESTROGEN IN EXPERIMENTAL TARDIVE DYSKINESIAGORDON JH; BORISON RL; DIAMOND BI et al.1980; NEUROLOGY; USA; DA. 1980; VOL. 30; NO 5; PP. 551-554; BIBL. 23 REF.Article

POTENTIAL HAZARDS AND APPLICATIONS OF LITHIUM IN ANESTHESIOLOGYHAVDALA HS; BORISON RL; DIAMOND BI et al.1979; ANESTHESIOLOGY; USA; DA. 1979; VOL. 50; NO 6; PP. 534-537; BIBL. 29 REF.Article

MODULATION OF DOPAMINE RECEPTOR SENSITIVITY BY ESTROGENGORDON JH; BORISON RL; DIAMOND BI et al.1980; BIOL. PSYCHIATRY; USA; DA. 1980; VOL. 15; NO 3; PP. 389-396; BIBL. 1 P.Article

METABOLISM OF AN AMINO ACID WITH ANTIDEPRESSANT PROPERTIESBORISON RL; MAPLE PJ; HAVDALA HS et al.1978; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1978; VOL. 21; NO 2; PP. 363-366; BIBL. 6 REF.Article

PHENYLETHYLAMINE AND BRAIN FUNCTIONSABELLI HC; BORISON RL; DIAMOND BI et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 13; PP. 1707-1711; BIBL. 53 REF.Article

POSTSYNAPTIC EFFICACY OF DOPAMINE: POSSIBLE SUPPRESSION BY ESTROGENGORDON JH; GORSKI RA; BORISON RL et al.1980; PHARMACOL. BIOCHEM. BEHAV.; USA; DA. 1980; VOL. 12; NO 4; PP. 515-518; BIBL. 32 REF.Article

REGIONAL LOCALIZATION OF 2-PHENYLETHYLAMINE IN HUMAN BRAIN.BORISON RL; LEMUS F; REYES M et al.1977; RES. COMMUNIC. PSYCHOL. PSYCHIATRY BEHAV.; U.S.A.; DA. 1977; VOL. 2; NO 3; PP. 193-201; BIBL. 1 P. 1/2Article

LITHIUM PREVENTION OF AMPHETAMINE-INDUCED "MANIC" EXCITEMENT AND OF RESERPINE-INDUCED "DEPRESSION" IN MICE: POSSIBLE ROLE OF 2-PHENYLETHYLAMINEBORISON RL; SABELLI HC; MAPLE PJ et al.1978; PSYCHOPHARMACOLOGY; DEU; DA. 1978; VOL. 59; NO 3; PP. 259-262; BIBL. 13 REF.Article

BIOCHEMICAL PLASTICITY OF SYNAPTIC TRANSMISSION: A CRITICAL REVIEW OF DALE'S PRINCIPE.SABELLI HC; MOSNAIM AD; VAZQUEZ AJ et al.1976; BIOL. PSYCHIATRY; U.S.A.; DA. 1976; VOL. 11; NO 4; PP. 481-524; BIBL. 6 P.Article

DOPAMINE BINDING FOLLOWING PROLONGED HALOPERIDOL PRETREATMENT.HITRI A; WEINER WJ; BORISON RL et al.1978; ANN. NEUROL.; U.S.A.; DA. 1978; VOL. 3; NO 2; PP. 134-140; BIBL. 35 REF.Article